- About NephU
- Meet The Team
- Supporting Organizations
- Community Advisors
- Contact Us
- Diversity, Equity, & Inclusion
- Resource Center
- Rare Kidney Diseases (PKD, IgAN, & Others)
- Kidney Disease & Mental Health
- Kidney Disease & Comorbid Conditions
- Transplantation & Dialysis
- NephU Nutrition & The NephChefTM
- Patient Resources
Leaders in nephrology will discuss healthcare challenges amidst COVID-19, telemedicine, and the future of nephrology.
*Speakers are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc (OPDC). Tazin Aijaz, PharmD, BCPS is an employee of OPDC.
Oklahoma University Medicine*
Dr Benjamin D Cowley Jr. is currently Professor of Medicine and Section Chief, Nephrology and Hypertension at the University of Oklahoma Health Science Center and at the Oklahoma City Veterans Administration Medical Center. Dr Cowley is the John Gammill Professor in Polycystic Kidney Disease. He graduated from the Baylor College of Medicine in 1981. Following that, he completed a residency in Internal Medicine and a fellowship in Nephrology at the University of Kansas Medical Center in Kansas City, KS. He is also the President of the Board of Directors, for the Oklahoma Foundation for Kidney Disease and serves on the Board of Directors of LifeShare Transplant Donor Services of Oklahoma. Dr Cowley is currently the United Network for Organ Sharing designated physician for the University of Oklahoma Health Science Center Kidney Transplant Program and the University of Oklahoma Health Science Center Pancreas Transplant Program.
Dr. Hain is a Ph.D. trained, board certified adult and gerontological nurse practitioner who has practice experience within nephrology nursing, memory disorder clinic and hospice care. Dr. Hain’s scholarly endeavors have focused on improving health outcomes of older adults with chronic kidney disease and those with cognitive impairment, and she has authored numerous peer reviewed publications on these topics. Her current research interests are strategies to improve self-management in an ethnically diverse population with CKD Stage 4 and 5 and Supportive (Palliative) care of older adults with CKD stage 4-5 and ESRD. Dr. Hain’s teaching has focused on care of individuals with chronic disease such as diabetes, chronic kidney disease, pulmonary disease, and cognitive impairment.
Dr. Frederic Rahbari is the director of Cystic Kidney Diseases Clinic at Emory University and has been a nephrologist practicing at Emory University Hospital in Atlanta, GA since 2006. Dr. Rahbari attended medical school at Université de Bordeaux in France and completed a residency program at the same institution. After moving to the US, Dr. Rahbari did clinical and translational research on oxidative stress at New York Medical College and subsequently redid three years of residency training in internal medicine at St. Vincent Hospital -Columbia University College of Physicians and Surgeons. He has also completed a fellowship in nephrology at Emory University. Dr. Rahbari has been a principal investigator in several PKD trials and is a member of the Scientific Advisory Committee of the Polycystic Kidney Disease Foundation.
University of California San Diego*
Dr. Pranav Garimella is board-certified nephrologist and assistant professor and director of the dialysis outreach program in the department of medicine and nephrology at UC San Diego. He received his training in India, Chicago, and completed his fellowship at Tufts University, training in clinical nephrology with a focus on polycystic kidney disease with Dr. Ron Perrone. His research endeavors have led to multiple NIH-funded studies and numerous peer-reviewed publications on the topic of kidney diseases. He has an ongoing NIH grant for his research elucidating aspects of kidney disease and has been the recipient of a multitude of teaching and clinical excellence awards. He is also involved in initiatives to develop programs specifically targeted at minority populations in an effort to improve health literacy and potentially clinical outcomes.
Otsuka Pharmaceutical Development & Commercialization, Inc.*
Tazin Aijaz, PharmD, BCPS, is a Nephrology Clinical & Scientific Director at Otsuka Pharmaceutical Development and Commercialization. She earned her Doctor of Pharmacy from the University of Cincinnati in Cincinnati, Ohio and then completed her clinical residency training at the Atlanta VA Medical Center with a focus in internal medicine and psychiatry. Prior to joining Otsuka, Dr Aijaz held various positions within the pharmaceutical industry in several therapeutic areas including immunology, movement disorders, and epilepsy.
Online via NephU.org
NephU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI) - committed supporters of the Kidney Health Community. The information provided through NephU is intended for the educational benefit of health care professionals and others who support care for those with kidney disease and other related conditions. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing NephU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by NephU. Some of the contributors may be paid consultants of OPDC and/or OAPI.May 2020 MRC2.CORP.X.04767
February 14 from 12:00 pm to 1:00 pm
- Resource Center
- Patient Resources